Midwest research Group

Saint Charles, Missouri 63304

5 studies enrolling now · 39 studies all time

What they study most

ADHD, ADHD Specifically With Executive Function Impairment, Adult Attention Deficit Hyperactivity Disorder, Anhedonia, Anxiety, Separation, Attention Deficit Disorder With Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder, Bipolar Depression

Studies at this site

• Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients — Recruiting now
• Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients — Recruiting now
• RE104 Safety and Efficacy Study in Generalized Anxiety Disorder — Recruiting now
• An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1) — Recruiting now
• A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA) — Recruiting now
• Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder — Completed
• Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults — Completed
• A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder — Running, not enrolling
• A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Stopped early
• Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients — Completed
• A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy — Completed
• Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD — Running, not enrolling
• Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD — Stopped early
• A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder — Completed
• A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder — Completed
• A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy — Completed
• A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder. — Completed
• Guided ADHD Therapy for Managing the Extent and Severity of Symptoms — Completed
• Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD — Completed
• Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents) — Completed
• Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult) — Completed
• A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
• SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP) — Completed
• Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
• Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) — Completed
• Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) — Completed
• Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) — Completed
• Dasotraline Pediatric ADHD Study — Completed
• Software Treatment for Actively Reducing Severity of ADHD — Completed
• Software Treatment for Actively Reducing Severity of ADHD - Follow Up — Completed
• A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD — Completed
• Dasotraline Adult ADHD Study — Completed
• Open-label Safety Study in Adults With ADHD — Completed
• Lurasidone Low-Dose - High-Dose Study Study — Completed
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression — Completed
• Adult Attention Deficit Hyperactivity Disorder — Completed
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on) — Completed
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) — Completed
• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia — Completed